
MeTis липид 5 is an ионизируемый липид featuring a pyrazole-based headgroup and biodegradable C8-ester twin tails developed by MeTis Pharmaceuticals (Patent CN118290339B). It demonstrated breakthrough in vivo efficacy (7.08E+10 photons, luciferase assay), surpassing MC3 липид by 8.8-fold in systemic mRNA delivery. The molecule achieves optimal safety-profile (96.4% клетка viability) and encapsulation efficiency (96.4%), forming LNPs of 108.9 nm (PDI 0.17) at N/P 6. Its ester-enabled rapid metabolization and balanced hydrophobicity position липид 5 as a candidate for next-gen mRNA therapeutics.
MeTis Lipid 5 is an ionizable lipid featuring a pyrazole-based headgroup and biodegradable C8-ester twin tails developed by MeTis Pharmaceuticals (Patent CN118290339B). It demonstrated breakthrough in vivo efficacy (7.08E+10 photons, luciferase assay), surpassing MC3 lipid by 8.8-fold in systemic mRNA delivery. The molecule achieves optimal safety-profile (96.4% cell viability) and encapsulation efficiency (96.4%), forming LNPs of 108.9 nm (PDI 0.17) at N/P 6. Its ester-enabled rapid metabolization and balanced hydrophobicity position lipid 5 as a candidate for next-gen mRNA therapeutics.
Вращайте мышью · Колесо — масштаб
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.